Biotech announced that Dongtai Qiheng and its co-actor Huitianze held a total of 24.5528 million shares of the company, accounting for 5.93% of the company's total share capital. Dongtai Qiheng plans to reduce its holdings of the company through centralized bidding and bulk transactions due to the withdrawal of investment projects and capital arrangements. In total, no more than 8.2816 million shares, accounting for no more than 2% of the company's total share capital.

Zhitongcaijing · 10/14 12:41
Biotech announced that Dongtai Qiheng and its co-actor Huitianze held a total of 24.5528 million shares of the company, accounting for 5.93% of the company's total share capital. Dongtai Qiheng plans to reduce its holdings of the company through centralized bidding and bulk transactions due to the withdrawal of investment projects and capital arrangements. In total, no more than 8.2816 million shares, accounting for no more than 2% of the company's total share capital.